BOD1P1

Across TCGA pan-cancer cohorts, BOD1P1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated BOD1P1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher BOD1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BOD1P1 expression acts as an unfavorable survival marker, although some lineages such as TGCT and SKCM show a favorable association.

ACC, MESO, and BRCA are the cancer types where BOD1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.624	<.001	135	view →
MESO	OS	Tertile	III,IV	0.036	0.563	<.001	54	view →
BRCA	DFS	Tertile	II,III,IV	0.799	0.894	.019	36	view →
READ	OS	Tertile	IV	0.077	1.000	.014	27	view →
COAD	DFS	Tertile	III,IV	0.513	0.683	.029	24	view →
TGCT	DFS	Tertile	All	1.000	0.754	.007	18	view →
KIRC	DFS	Tertile	III,IV	0.437	0.657	.043	12	view →
LUAD	OS	Tertile	All	0.545	0.690	.033	12	view →
SKCM	DFS	Tertile	All	0.459	0.183	.024	3	view →
DLBC	OS	Quartile	II,III,IV	0.640	1.000	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

BOD1P1–ACC (DFS)

Open the ACC breakdown →